This activity was originally broadcast as part of the 2024 Directions in Pharmacy conference.
Program Description
Allergic conjunctivitis (AC) results from inflammation that occurs when allergens come into contact with the most external layers of the eye. Complications may arise due to excessive eye rubbing, coinfections, or inappropriate medication or steroid use. Management of ocular allergies including AC often involves a combination of preventive, nonpharmacologic, and pharmacologic measures, though the variety of OTC products available for treatment of AC symptoms can require navigation and guidance. This program will review available treatment classes of OTC agents that are preferred first-line treatments for AC, including safety and efficacy of dual-activity medications, for pharmacists to guide patients with OTC product selection and individualize care. Educational points about allergen avoidance, OTC medication administration and adherence, and other self-care measures for patients with AC will also be discussed.
Target Audience: Health system and retail pharmacists
Type of Activity: Application
Release date: June 24, 2024
Expiration date: June 24, 2025
Learner level: Foundational
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Classify the mechanisms of inflammation involved in allergic conjunctivitis (AC) and the burden of symptoms for patients
- Identify appropriate OTC products for patients with AC based on patient preference and specific symptoms
- Examine individualized treatment recommendations for patients with AC to reduce symptom burden and prevent associated complications
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here